Cite
Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials—II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma
MLA
Andreas S. Beutler, and Jonathan D. Schwartz. “Therapy for Unresectable Hepatocellular Carcinoma: Review of the Randomized Clinical Trials—II: Systemic and Local Non-Embolization-Based Therapies in Unresectable and Advanced Hepatocellular Carcinoma.” Anti-Cancer Drugs, vol. 15, June 2004, pp. 439–52. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eb8bbc302efa61158dc8dd3c84556972&authtype=sso&custid=ns315887.
APA
Andreas S. Beutler, & Jonathan D. Schwartz. (2004). Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials—II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anti-Cancer Drugs, 15, 439–452.
Chicago
Andreas S. Beutler, and Jonathan D. Schwartz. 2004. “Therapy for Unresectable Hepatocellular Carcinoma: Review of the Randomized Clinical Trials—II: Systemic and Local Non-Embolization-Based Therapies in Unresectable and Advanced Hepatocellular Carcinoma.” Anti-Cancer Drugs 15 (June): 439–52. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....eb8bbc302efa61158dc8dd3c84556972&authtype=sso&custid=ns315887.